Gujarat Themis Biosyn Raises INR 585 Crores via NCDs for Japan Acquisition
Gujarat Themis Biosyn Ltd 路 Others (Uncategorized) 路 17 Sept 2026, 12:53 am
Gujarat Themis Biosyn Raises INR 585 Crores via NCDs for Japan Acquisition Gujarat Themis Biosyn allotted secured, unlisted NCDs worth INR 585 Crores on private placement on 16th Sep'26. The proceeds will fund the acquisition of MicroBiopharm Japan Co., Ltd via its Japanese subsidiary and support general corporate purposes. The issue comprises Series 1 of INR 295 Crores (60-month tenure, 10% p.a. coupon) and Series 2 of INR 290 Crores (18-month tenure, 17.75% p.a. coupon). Both tranches feature monthly compounded interest paid quarterly starting from the 13th month and are backed by company assets and promoter guarantees.
Original exchange filing (PDF)
More announcements from Gujarat Themis Biosyn Ltd
- Recording of Analysts Meet held on 16.11.2026 路 17 Nov 2026
- Please refer to the attached Analysts Presentation 路 16 Nov 2026
- Please refer to the attachment 路 16 Nov 2026
- Please refer to the intimation of resignation of Company Secretary & Compliance Officer. 路 15 Nov 2026
- Please refer to the attachment 路 14 Nov 2026
- Kindly refer to the Un-audited Standalone & Consolidated Financial Results for the quarter and half year ended 30.09.2026 路 14 Nov 2026
- Gujarat Themis Biosyn Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 14 Nov 2026
- Outcome of the Board Meeting held on 14.11.2026 路 14 Nov 2026
